{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:41:22Z","timestamp":1783035682011,"version":"3.54.6"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Myasthenia gravis (MG) is an autoimmune disease mediated by B cells secreting autoantibodies. Regulatory B (Breg) cells confirmed to have an immunosuppressive function play an important role in many autoimmune diseases. However, what about the changes in Breg cells in the thymus and peripheral blood of MG patients? The changes in the proportion of Breg cells in the peripheral blood of 41 MG patients without any drug treatment and 30 healthy controls were detected by flow cytometry. We found that the proportions of CD19<jats:sup>+<\/jats:sup>IL-10<jats:sup>+<\/jats:sup>cells and CD19<jats:sup>+<\/jats:sup>CD24<jats:sup>hi<\/jats:sup>CD38<jats:sup>hi<\/jats:sup>cell subsets in MG patients were significantly lower than those in healthy controls. Then, we detected the proportion of CD19<jats:sup>+<\/jats:sup>IL-10<jats:sup>+<\/jats:sup>cells in thymus tissues of 10 healthy children, 4 healthy adults, and 12 MG patients by flow cytometry. However, the percentage of CD19<jats:sup>+<\/jats:sup>IL-10<jats:sup>+<\/jats:sup>cells was highest in healthy children (~8%), followed by healthy adults (~3%), and was lowest in MG patients (~0.5%). CD19<jats:sup>+<\/jats:sup>CD24<jats:sup>hi<\/jats:sup>CD38<jats:sup>hi<\/jats:sup>B cells exerted immunosuppressive functions in healthy people but were refractory in MG patients. Moreover, p-STAT3 downstream of CD40 may be impaired in CD24<jats:sup>hi<\/jats:sup>CD38<jats:sup>hi<\/jats:sup>B cells from the peripheral blood of MG patients.<\/jats:p>","DOI":"10.3389\/fneur.2022.808322","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T05:30:55Z","timestamp":1646026255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Regulatory B Cells Are Decreased and Functionally Impaired in Myasthenia Gravis Patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Ye","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaji","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1196\/annals.1405.040","article-title":"Myasthenia gravis in the elderly: is it different?","volume":"1132","author":"Aarli","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","article-title":"Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis","volume":"65","author":"Somnier","year":"2005","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B4","first-page":"695","article-title":"Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody","volume":"63","author":"Konishi","year":"2011","journal-title":"Brain Nerve."},{"key":"B5","doi-asserted-by":"publisher","first-page":"ii85","DOI":"10.1136\/annrheumdis-2012-202341","article-title":"Regulatory cell subsets in the control of autoantibody production related to systemic autoimmunity","volume":"72","author":"Fujio","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/251550a0","article-title":"B-cell suppression of delayed hypersensitivity reactions","volume":"251","author":"Katz","year":"1974","journal-title":"Nature."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nm.2003","article-title":"A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties","volume":"15","author":"Rafei","year":"2009","journal-title":"Nat Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/art.22810","article-title":"Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy","volume":"56","author":"Anolik","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.4049\/jimmunol.1600218","article-title":"Induction and differentiation of IL-10-producing regulatory B cells from healthy blood donors and rheumatoid arthritis patients","volume":"198","author":"Banko","year":"2017","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4049\/jimmunol.167.2.1081","article-title":"Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice","volume":"167","author":"Tian","year":"2001","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.4049\/jimmunol.156.7.2345","article-title":"CD40-mediated signaling in B cells. Balancing cell survival, growth, and death","volume":"156","author":"Kehry","year":"1996","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1212\/NXI.0000000000000077","article-title":"Characterization of B cells in muscle-specific kinase antibody myasthenia gravis","volume":"2","author":"Guptill","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/mus.23951","article-title":"Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis","volume":"49","author":"Sun","year":"2014","journal-title":"Muscle Nerve."},{"key":"B15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S1074-7613(00)80281-2","article-title":"Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells","volume":"6","author":"Hanissian","year":"1997","journal-title":"Immunity."},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity."},{"key":"B17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity."},{"key":"B18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","article-title":"Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells","volume":"36","author":"Bosma","year":"2012","journal-title":"Immunity."},{"key":"B19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood."},{"key":"B21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","article-title":"Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission","volume":"239","author":"Knippenberg","year":"2011","journal-title":"J Neuroimmunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jdermsci.2017.01.010","article-title":"Corrigendum to \u201cIL-10-producing regulatory B cells are decreased in patients with psoriasis\u201d","volume":"86","author":"Hayashi","year":"2017","journal-title":"J Dermatol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/art.38666","article-title":"Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity","volume":"66","author":"Daien","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/rheumatology\/keu136","article-title":"Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"53","author":"Todd","year":"2014","journal-title":"Rheumatology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jneuroim.2015.10.023","article-title":"IL-10 derived from CD1dhiCD5(+) B cells regulates experimental autoimmune myasthenia gravis","volume":"289","author":"Sheng","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.4049\/jimmunol.1303397","article-title":"CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis","volume":"193","author":"Sheng","year":"2014","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fneur.2017.00034","article-title":"B10 Cell frequencies and suppressive capacity in myasthenia gravis are associated with disease severity","volume":"8","author":"Yi","year":"2017","journal-title":"Front Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneuroim.2016.05.004","article-title":"Impaired regulatory B cells in myasthenia gravis","volume":"297","author":"Sheng","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12035-014-8985-1","article-title":"Intrathymic Tfh\/B cells interaction leads to ectopic GCs formation and anti-AChR antibody production: central role in triggering MG occurrence","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.4049\/jimmunol.164.10.5221","article-title":"B lymphopoiesis in the thymus","volume":"164","author":"Akashi","year":"2000","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0165-5728(02)00038-3","article-title":"Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis","volume":"125","author":"Roxanis","year":"2002","journal-title":"J Neuroimmunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/acn3.645","article-title":"Regulatory B cells in myasthenia gravis are differentially affected by therapies","volume":"5","author":"Yilmaz","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"73774","DOI":"10.18632\/oncotarget.17908","article-title":"Significance of B10 cell in patients with thymoma complicated with myasthenia gravis","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.808322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:50:56Z","timestamp":1674867056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.808322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":33,"alternative-id":["10.3389\/fneur.2022.808322"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.808322","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"article-number":"808322"}}